Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Moore

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Scientific Reports|May 24, 2016
Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G geneSeth A Schobel, Karla M Stucker, Martin L Moore, et al.
Journal of Virology|October 29, 2020
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune EvasionStacey Human, Anne L Hotard, Christina A Rostad, et al.
Viruses|August 22, 2018
The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron TomographyZunlong Ke, Rebecca S Dillard, Tatiana Chirkova, et al.
Plos Pathogens|May 7, 2016
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionMichael G Currier, Sujin Lee, Christopher C Stobart, et al.
The Journal of Infectious Diseases|October 25, 2022
An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c MiceMolly K Roe, Maria A Perez, Hui-Mien Hsiao, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Nature Communications|December 22, 2016
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationChristopher C Stobart, Christina A Rostad, Zunlong Ke, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
Vaccines|May 26, 2026
Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural InfectionDavide Botta, Michael D Schultz, Aaron Silva-Sanchez, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infectionDavide Botta, Michael D Schultz, Aaron Silva-Sanchez, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Scientific Reports|May 24, 2016
Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G geneSeth A Schobel, Karla M Stucker, Martin L Moore, et al.
Journal of Virology|October 29, 2020
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune EvasionStacey Human, Anne L Hotard, Christina A Rostad, et al.
Viruses|August 22, 2018
The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron TomographyZunlong Ke, Rebecca S Dillard, Tatiana Chirkova, et al.
Plos Pathogens|May 7, 2016
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionMichael G Currier, Sujin Lee, Christopher C Stobart, et al.
The Journal of Infectious Diseases|October 25, 2022
An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c MiceMolly K Roe, Maria A Perez, Hui-Mien Hsiao, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Nature Communications|December 22, 2016
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationChristopher C Stobart, Christina A Rostad, Zunlong Ke, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
Vaccines|May 26, 2026
Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural InfectionDavide Botta, Michael D Schultz, Aaron Silva-Sanchez, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infectionDavide Botta, Michael D Schultz, Aaron Silva-Sanchez, et al.
Pageof 9